NO984725L - Depot antiprogestin treatment - Google Patents

Depot antiprogestin treatment

Info

Publication number
NO984725L
NO984725L NO984725A NO984725A NO984725L NO 984725 L NO984725 L NO 984725L NO 984725 A NO984725 A NO 984725A NO 984725 A NO984725 A NO 984725A NO 984725 L NO984725 L NO 984725L
Authority
NO
Norway
Prior art keywords
antiprogestin
depot
antiprogestin treatment
treatment
acth
Prior art date
Application number
NO984725A
Other languages
Norwegian (no)
Other versions
NO984725D0 (en
Inventor
Gary D Hodgen
Original Assignee
Hampton Roads Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hampton Roads Medical College filed Critical Hampton Roads Medical College
Priority to NO984725A priority Critical patent/NO984725L/en
Publication of NO984725D0 publication Critical patent/NO984725D0/en
Publication of NO984725L publication Critical patent/NO984725L/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Depot-administreringsavlevering av antiprogestin unngår den uønskede perifere virkningen, spesielt den på ACTH/kortisolaksen. En effektiv mengde av antiprogestinet administreres og adsorberes/absorberes av den omgivende vev. Det terapeutiske resultatet innbefatter langvarig, men reversibel, amenore.Depot administration delivery of antiprogestin avoids the undesirable peripheral effect, especially that on the ACTH / cortisol axis. An effective amount of the antiprogestin is administered and adsorbed / absorbed by the surrounding tissue. The therapeutic result includes prolonged, but reversible, amenorrhea.

NO984725A 1998-10-09 1998-10-09 Depot antiprogestin treatment NO984725L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO984725A NO984725L (en) 1998-10-09 1998-10-09 Depot antiprogestin treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO984725A NO984725L (en) 1998-10-09 1998-10-09 Depot antiprogestin treatment

Publications (2)

Publication Number Publication Date
NO984725D0 NO984725D0 (en) 1998-10-09
NO984725L true NO984725L (en) 1999-05-19

Family

ID=19902500

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984725A NO984725L (en) 1998-10-09 1998-10-09 Depot antiprogestin treatment

Country Status (1)

Country Link
NO (1) NO984725L (en)

Also Published As

Publication number Publication date
NO984725D0 (en) 1998-10-09

Similar Documents

Publication Publication Date Title
TR199700930T2 (en) Method and kit to prevent erectile dysfunction.
NZ285159A (en) Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene
GR3032512T3 (en) Sexual steroid-containing transdermal therapeutic systems
DE60023476D1 (en) COMBINATION OF DOCTAXEL AND RHUMAB HER2 FOR CANCER TREATMENT
DE69633405D1 (en) TREATING PROSTATE CANCER WITH LHRH ANTAGONISTS
MXPA02011099A (en) Delivery devices for treatment of vascular disease.
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
AU2003301190A1 (en) Administration of capsaicinoids
BR9407560A (en) Thermoplastic elastomer copolymers grafted with silicone and hair and skin treatment compositions containing these copolymers
BR9707637A (en) Implantable implant system intended for subcutaneous or local administration and pharmaceutical set
AU2002342765A1 (en) Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
ATE267583T1 (en) MEDICINAL PREPARATIONS FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS
IL133762A0 (en) Transdermal therapeutic system (tts) for the administration of levonorgestral
NO20101070L (en) Method of dosing a drug, as well as dosage form
SE9603725D0 (en) New teatment
ATE356637T1 (en) DRUGS CONTAINING SUPRAMOLECULAR COMPLEXES
NO984725L (en) Depot antiprogestin treatment
DK0871467T3 (en) New formulation for delivery of peptide
GR900100489A (en) Contraception method for men
HRP20040370B1 (en) Use of (11c, 17c)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one in the treatment of major depressive disorder
NO953003L (en) Use of ifenprodil and its diastereoisomers for the preparation of medical preparations
BR9804054A (en) Antiprogestin deposit therapy method.
FR2812549B1 (en) DALFOPRISTINE / QUINUPRISTINE ASSOCIATIONS WITH CEFPIROME
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application